B.C. in court against pharma companies in bid to certify opioid class-action lawsuit
- The British Columbia government is in court seeking certification for a class-action lawsuit against health care and pharmaceutical companies over the costs of the opioid crisis.
- The companies sought a delay in the certification hearing while the Supreme Court rules on their constitutional challenge, but the judge denied the adjournment.
- The certification hearing is expected to last about four weeks, after which a civil trial will determine if the companies are liable for damages.
35 Articles
35 Articles
B.C. in court against pharma companies in bid to certify opioid class action lawsuit
B.C. Attorney General Niki Sharma says a court hearing in Vancouver on Monday represents a "new step" in the battle against opioid makers and marketers as the province seeks to certify a class action on behalf of other jurisdictions in Canada.
B.C. in court against pharma companies in bid to certify opioid class-action lawsuit
VANCOUVER -- B.C. Attorney General Niki Sharma says a court hearing today in Vancouver represents a "new step" in the battle against opioid makers and marketers as the province seeks to certify a class action on behalf of other Canadian governments.
B.C. in court against pharma companies in bid to certify opioid class-action lawsuit
The British Columbia government goes up against dozens of health care and pharmaceutical companies in court Monday in a bid to get certification for a class-action lawsuit over the costs of the opioid crisis.
B.C. in court against pharma companies in bid to certify opioid class-action lawsuit
VANCOUVER — The British Columbia government goes up against dozens of health care and pharmaceutical companies in court today in a bid to get certification for a class-action lawsuit over the costs of the opioid crisis.
Coverage Details
Bias Distribution
- 63% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage